Filing Details
- Accession Number:
- 0001348362-25-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-30 17:12:54
- Reporting Period:
- 2025-07-29
- Filing Date:
- 2025-07-30
- Accepted Time:
- 2025-07-30 17:12:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348362 | Lexaria Bioscience Corp. | LEXX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1103780 | Christopher Bunka | Suite 100 740 Mccurdy Road Kelowna A1 V1X 2P7 | Yes | No | No | No |
Transaction Summary
| Purchased: | 27,500 shares | Avg. Price: $0.92 | Total Value: $25,241.29 |
| Number of Shares After Transactions: | 281,912 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2025-07-29 | 15,600 | $0.92 | 270,012 | No | 4 | P | Indirect | Private Holding Company |
| Common Shares | Acquisiton | 2025-07-30 | 11,900 | $0.91 | 281,912 | No | 4 | P | Indirect | Private Holding Company |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Private Holding Company |
| No | 4 | P | Indirect | Private Holding Company |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 373,543 | Direct | |
| Common Shares | 254,412 | Indirect | Private Holding Company |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Options | $3.00 | 2021-04-26 | 2026-04-26 | 26,000 | 26,000 | Direct |
| Common Shares | Stock Options | $3.00 | 2021-06-08 | 2026-06-08 | 23,334 | 49,334 | Direct |
| Common Shares | Stock Options | $3.00 | 2021-09-01 | 2026-09-01 | 15,000 | 64,334 | Direct |
| Common Shares | Stock Options | $2.91 | 2022-08-29 | 2027-08-29 | 30,000 | 94,334 | Direct |
| Common Shares | Stock Options | $1.15 | 2023-10-26 | 2028-10-26 | 30,000 | 124,334 | Direct |
| Common Shares | Stock Options | $2.36 | 2024-04-26 | 2029-04-26 | 49,500 | 173,834 | Direct |
| Common Shares | Stock Options | $1.04 | 2025-05-15 | 2030-05-15 | 11,000 | 184,834 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-04-26 | 26,000 | 26,000 | Direct |
| 2026-06-08 | 23,334 | 49,334 | Direct |
| 2026-09-01 | 15,000 | 64,334 | Direct |
| 2027-08-29 | 30,000 | 94,334 | Direct |
| 2028-10-26 | 30,000 | 124,334 | Direct |
| 2029-04-26 | 49,500 | 173,834 | Direct |
| 2030-05-15 | 11,000 | 184,834 | Direct |
Billionaire Hedge Funds
